Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | AZN | AMGN | GILD | VRTX |
| Company | Morphosys Ag ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.38 | 90.37 | 321.21 | 122.00 | 454.28 |
| High | 19.15 | 91.61 | 325.11 | 122.98 | 455.00 |
| Low | 18.38 | 90.12 | 319.06 | 119.90 | 449.48 |
| Latest | 18.96 | 91.60 | 324.85 | 119.96 | 455.20 |
| Change | +0.45 | +1.77 | +7.11 | +0.35 | +3.16 |
| % Change | +2.43% | +1.97% | +2.24% | +0.29% | +0.70% |
| Volume | 19,100 | 4,426,215 | 2,302,402 | 3,437,558 | 714,306 |
| 20-Day Average Volume | 25,605 | 5,697,922 | 2,804,237 | 6,888,255 | 1,359,031 |
| Previous Close | 18.51 | 89.83 | 317.74 | 119.61 | 452.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.58 | 90.72 | 333.42 | 123.97 | 438.47 |
| 20-Day Raw Stochastic | 81.19% | 54.42% | 35.24% | 12.95% | 77.65% |
| 20-Day Relative Strength | 57.86 | 59.16 | 51.78 | 46.70 | 59.92 |
| Weighted Alpha | +39.78 | +42.55 | +22.98 | +26.21 | +13.35 |
| Today's Opinion | 100% Buy | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.99% since 07/26/24 | +0.20% since 12/08/25 | +0.98% since 12/08/25 | -0.93% since 12/08/25 | +2.64% since 12/08/25 |
| Low | 18.32 on 07/29/24 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 19.15 on 08/02/24 | 91.66 on 12/10/25 | 324.66 on 12/15/25 | 123.74 on 12/11/25 | 456.00 on 12/12/25 |
| 1-Month | |||||
| %Chg | +4.75% since 07/02/24 | +2.65% since 11/14/25 | -3.67% since 11/14/25 | -3.97% since 11/14/25 | +3.79% since 11/14/25 |
| Low | 18.08 on 07/03/24 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 19.15 on 08/02/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +6.10% since 05/02/24 | +17.18% since 09/15/25 | +18.21% since 09/15/25 | +6.68% since 09/15/25 | +15.39% since 09/15/25 |
| Low | 17.80 on 05/03/24 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 19.50 on 05/16/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +71.27% since 02/02/24 | +22.90% since 06/13/25 | +9.87% since 06/13/25 | +9.17% since 06/13/25 | -0.38% since 06/13/25 |
| Low | 11.06 on 02/05/24 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 19.50 on 05/16/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,855,774 | 278,601,088 | 171,096,960 | 149,377,888 | 114,691,136 |
| Shares Outstanding, K | 150,621 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 257,890,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -205,350,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 29,900,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -341,960,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.20 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.24 on 04/29/24 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/29/24 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.76 | 14.51 | 15.04 | 29.13 |